ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #2,656Hybrid

Cancer Epidemiology Biomarkers & Prevention

Abbreviation (ISO):CANCER EPIDEM BIOMAR
•
Identifier (ISSN):1055-9965(Print)/1538-7755(Online)
•
Publisher:American Association for Cancer Research Inc.
Clarivate IF (2026)
3.7↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Epidemiology Biomarkers & Prevention

WoS Q2
24574.5520185.0620194.3420204.2520214.0920223.820233.720243.420253.72026
Annual Impact Factor Metric
Current (2026):3.7
Scopus SJR & RankScopus Q1
1.426
#2,656

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
223

223 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate2.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
264articles/year
19.12% Gold OA•93.1% Original Research

Aims & Scope

Cancer Epidemiology, Biomarkers & Prevention publishes original peer-reviewed, population-based research on cancer etiology, prevention, surveillance, and survivorship. The following topics are of special interest: descriptive, analytical, and molecular epidemiology; biomarkers including assay development, validation, and application; chemoprevention and other types of prevention research in the context of descriptive and observational studies; the role of behavioral factors in cancer etiology and prevention; survivorship studies; risk factors; implementation science and cancer care delivery; and the science of cancer health disparities. Besides welcoming manuscripts that address individual subjects in any of the relevant disciplines, CEBP editors encourage the submission of manuscripts with a transdisciplinary approach.

Topics Covered (Recognized by AI)
Medicine94.2%Biology91%Internal medicine89%Genetics84.8%Cancer72.1%Pathology64.1%Mathematics49.3%Chemistry46.4%Statistics44.6%Biochemistry43.1%Sociology40.4%Oncology38.6%Demography35.8%Environmental health33.4%Population28.8%Endocrinology27.6%Confidence interval26.4%Surgery25.8%Gene24.7%Breast cancer23.2%Psychology20.3%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q2
Rank129/333
IndexSCIE
JCRSCIE2026

PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Q1
Rank89/443
IndexSCIE
JCISCIE2026

ONCOLOGY

Q2
Rank96/333
IndexSCIE
JCISCIE2026

PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Q2
Rank116/443
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.7
Articles / Year195
Total Citations30
2025
IF3.4
Articles / Year864
Total Citations487
2024
IF3.7
Articles / Year764
Total Citations1,147
2023
IF3.8
Articles / Year1,194
Total Citations2,134
2022
IF4.09
Articles / Year582
Total Citations3,705

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,656Scopus Q1SCImago Profile
Scopus Coverage:1983, 1986, 1991-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.426

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.09

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,651 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,405
3-Year Documents707
Citable Documents685

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate53.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EpidemiologyQ1
Medicine (miscellaneous)Q1
OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Epidemiology Biomarkers & Prevention (abbr: CANCER EPIDEM BIOMAR, ISSN: 1055-9965) is a peer-reviewed international scholarly journal in the field of Medicine, published by American Association for Cancer Research Inc. in United States since 1991. The periodical holds a Journal Impact Factor (JIF) of 3.70, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.426 (Q1), an H-index of 223.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 264 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,651 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
American Association for Cancer Research Inc.
Publication Language
English
Frequency
Monthly
Founding Year
1991
Indexing & Databases
SCIEScopusPubMed
Editorial Address
AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: cd9b8d9a-e298-43da-a250-812c5538b7ae
Database Updated: 2026-10-01